Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Fernando Valiente-Echeverria"'
Autor:
Maria Jose Gallardo-Nelson, Marcos Cruces, Yolanda M. Gómez, Constanza Fuenzalida, Javiera Silva, Laura Aravena-Traipi, Eduardo Nuñez, Aracelly Gaete-Angel, Elizabeth Rivas-Yañez, Alexis M. Kalergis, Ricardo Soto-Rifo, Fernando Valiente-Echeverria
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Objectiveto evaluate the immune response to the SARS-CoV-2 vaccines in adults with immune-mediated rheumatic diseases (IMRDs) in comparison to healthy individuals, observed 1-20 weeks following the fourth vaccine dose. Additionally, to evaluate the i
Externí odkaz:
https://doaj.org/article/797b472d2e7b4a3ebae22d096dbd9f00
Autor:
Roslye Berrios, Cristian Gutierrez-Vera, Bárbara M. Schultz, Patricio Andres Astudillo Paredes, GUILLERMO HOPPE ELSHOLZ, Luisa Fernanda Duarte Peñaloza, Andrea Schilling Redlich, Jorge Soto, Richard Garcia, Felipe Melo-Gonzalez, Fernando Valiente-Echeverria
BackgroundMultiple vaccines against SARS-CoV-2 have been evaluated in clinical trials, but very few include the pediatric population. The inactivated vaccine CoronaVac® has shown to be safe and immunogenic in a phase 1/2 clinical trial in a pediatri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17d3c1de18a9519ff852cfacd1ca94e9
https://doi.org/10.1101/2022.02.15.22270973
https://doi.org/10.1101/2022.02.15.22270973
Autor:
Daniela Rivera-Pérez, Constanza Méndez, Benjamín Diethelm-Varela, Felipe Melo-González, Yaneisi Vázquez, Xing Meng, Qianqian Xin, Rodrigo A. Fasce, Jorge Fernández, Judith Mora, Eugenio Ramirez, Mónica L. Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Patricio Astudillo, Nicole Le Corre, Katia Abarca, Cecilia Perret, Pablo A. González, Jorge A. Soto, Susan M. Bueno, Alexis M. Kalergis
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundVaccine effectiveness against SARS-CoV-2 infection has been somewhat limited due to the widespread dissemination of the Omicron variant, its subvariants, and the immune response dynamics of the naturally infected with the virus.MethodsTwelv
Externí odkaz:
https://doaj.org/article/7c001b5b42b5457faed5b3a10f22f0e2
Autor:
Daniela, Toro-Ascuy, Aracelly, Gaete-Argel, Victoria, Rojas-Celis, Fernando, Valiente-Echeverria
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2209
The mechanisms involved in the posttranscriptional control of the replicative cycle of the human immunodeficiency virus (HIV), specifically the molecular events which allow the interaction between the viral genomic RNA (gRNA) and the cellular machine
Autor:
Cecilia Abreu, Claudia Ortega, Natalia Olivero-Deibe, Federico Carrión, Aracelly Gaete-Argel, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Rafaela Milan Bonotto, Alessandro Marcello, Sergio Pantano
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
The COVID-19 pandemic evolves constantly, requiring adaptable solutions to combat emerging SARS-CoV-2 variants. To address this, we created a pentameric scaffold based on a mammalian protein, which can be customized with up to 10 protein binding modu
Externí odkaz:
https://doaj.org/article/ee93bdde5a7444b6aa668d328feb22ee
Autor:
Constanza Méndez, Hernán F. Peñaloza, Bárbara M. Schultz, Alejandro Piña-Iturbe, Mariana Ríos, Daniela Moreno-Tapia, Patricia Pereira-Sánchez, Diane Leighton, Claudia Orellana, Consuelo Covarrubias, Nicolás M.S. Gálvez, Jorge A. Soto, Luisa F. Duarte, Daniela Rivera-Pérez, Yaneisi Vázquez, Alex Cabrera, Sergio Bustos, Carolina Iturriaga, Marcela Urzua, María S. Navarrete, Álvaro Rojas, Rodrigo A. Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Mónica Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Daniela Weiskopf, Alba Grifoni, Alessandro Sette, Gang Zeng, Weining Meng, José V. González-Aramundiz, Pablo A. González, Katia Abarca, Felipe Melo-González, Susan M. Bueno, Alexis M. Kalergis, María Soledad Navarrete, Constanza Del Río, Dinely Del Pino, Natalia Aguirre, Grecia Salinas, Franco Vega, Acsa Salgado, Thomas Quinteros, Marlene Ortiz, Marcela Puente, Alma Muñoz, Patricio Astudillo, Nicole Le Corre, Marcela Potin, Juan Catalán, Melan Peralta, Consuelo Zamanillo, Nicole Keller, Rocío Fernández, Sofía Aljaro, Sofía López, José Tomás González, Tania Weil, Luz Opazo, Paula Muñoz, Inés Estay, Miguel Cantillana, Liliana Carrera, Matías Masalleras, Paula Guzmán, Francisca Aguirre, Aarón Cortés, Luis Federico Bátiz, Javiera Pérez, Karen Apablaza, Lorena Yates, María de los Ángeles Valdés, Bernardita Hurtado, Veronique Venteneul, Constanza Astorga, Paula Muñoz-Venturelli, Pablo A. Vial, Andrea Schilling, Daniela Pavez, Inia Pérez, Amy Riviotta, Francisca González, Francisca Urrutia, Alejandra Del Río, Claudia Asenjo, Bárbara Vargas, Francisca Castro, Alejandra Acuña, Javiera Guzmán, Camila Astudillo, Carlos M. Pérez, Pilar Espinoza, Andrea Martínez, Marcela Arancibia, Harold Romero, Cecilia Bustamante, María Loreto Pérez, Natalia Uribe, Viviana Silva, Bernardita Morice, Marco Pérez, Marcela González, Werner Jensen, Claudia Pasten, M. Fernanda Aguilera, Nataly Martínez, Camila Molina, Sebastián Arrieta, Begoña López, Claudia Ortiz, Macarena Escobar, Camila Bustamante, Marcia Espinoza, Angela Pardo, Alison Carrasco, Miguel Montes, Macarena Saldías, Natalia Gutiérrez, Juliette Sánchez, Daniela Fuentes, Yolanda Calvo, Mariela Cepeda, Rosario Lemus, Muriel Suárez, Mercedes Armijo, Shirley Monsalves, Constance Marucich, Cecilia Cornejo, Ángela Acosta, Xaviera Prado, Francisca Yáñez, Marisol Barroeta, Claudia López, Paulina Donato, Martin Lasso, María Iturrieta, Juan Giraldo, Francisco Gutiérrez, María Acuña, Ada Cascone, Raymundo Rojas, Camila Sepúlveda, Mario Contreras, Yessica Campisto, Pablo González, Zoila Quizhpi, Mariella López, Vania Pizzeghello, Stephannie Silva
Publikováno v:
EBioMedicine, Vol 91, Iss , Pp 104563- (2023)
Summary: Background: The Omicron variant has challenged the control of the COVID-19 pandemic due to its immuno-evasive properties. The administration of a booster dose of a SARS-CoV-2 vaccine showed positive effects in the immunogenicity against SARS
Externí odkaz:
https://doaj.org/article/ada72f7a33e042e3b8078e201eaafcb4
Autor:
Leonardo Vargas, Nicolás Valdivieso, Fabián Tempio, Valeska Simon, Daniela Sauma, Lucía Valenzuela, Caroll Beltrán, Loriana Castillo-Delgado, Ximena Contreras-Benavides, Mónica L. Acevedo, Johanna Acevedo, Rafael I. Gonzalez, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Mario Rosemblatt, Mercedes Lopez, Fabiola Osorio, María Rosa Bono
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-13 (2022)
Abstract Background Chile was severely affected by COVID19 outbreaks but was also one of the first countries to start a nationwide program to vaccinate against the disease. Furthermore, Chile became one of the fastest countries to inoculate a high pe
Externí odkaz:
https://doaj.org/article/6b8f00289e5c4eaabb376b33a3001598
Autor:
Aracelly Gaete-Argel, Vicente Saavedra-Alarcón, Denis Sauré, Luis Alonso-Palomares, Mónica L. Acevedo, Marion Alarcón, Susan M. Bueno, Alexis M. Kalergis, Ricardo Soto-Rifo, Fernando Valiente-Echeverría, Claudia P. Cortes
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionBooster doses of SARS-CoV-2 vaccines improve seroconversion rates in solid organ transplant recipients (SOTRs) but the impact of homologous and heterologous booster doses in neutralizing antibody (NAb) titers and their ability to interfer
Externí odkaz:
https://doaj.org/article/72f56cbebb094dc19df8a6b1e11c4057
Autor:
Jorge A. Soto, Felipe Melo-González, Cristián Gutierrez-Vera, Bárbara M. Schultz, Roslye V. Berríos-Rojas, Daniela Rivera-Pérez, Alejandro Piña-Iturbe, Guillermo Hoppe-Elsholz, Luisa F. Duarte, Yaneisi Vázquez, Daniela Moreno-Tapia, Mariana Ríos, Pablo A. Palacios, Richard Garcia-Betancourt, Álvaro Santibañez, Gaspar A. Pacheco, Constanza Mendez, Catalina A. Andrade, Pedro H. Silva, Benjamín Diethelm-Varela, Patricio Astudillo, Mario Calvo, Antonio Cárdenas, Marcela González, Macarena Goldsack, Valentina Gutiérrez, Marcela Potin, Andrea Schilling, Lorena I. Tapia, Loreto Twele, Rodolfo Villena, Alba Grifoni, Alessandro Sette, Daniela Weiskopf, Rodrigo A. Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Mónica L. Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Angello Retamal-Díaz, Nathalia Muñoz-Jofré, Xing Meng, Qianqian Xin, Eduardo Alarcón-Bustamante, José V. González-Aramundiz, Nicole Le Corre, María Javiera Álvarez-Figueroa, Pablo A. González, Katia Abarca, Cecilia Perret, Leandro J. Carreño, Susan M. Bueno, Alexis M. Kalergis
Publikováno v:
mBio, Vol 13, Iss 6 (2022)
ABSTRACT Multiple vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been evaluated in clinical trials. However, trials addressing the immune response in the pediatric population are scarce. The inactivated vaccine Cor
Externí odkaz:
https://doaj.org/article/cf113e0121754f51995644752d348004
Autor:
Nicolás MS Gálvez, Gaspar A Pacheco, Bárbara M Schultz, Felipe Melo-González, Jorge A Soto, Luisa F Duarte, Liliana A González, Daniela Rivera-Pérez, Mariana Ríos, Roslye V Berrios, Yaneisi Vázquez, Daniela Moreno-Tapia, Omar P Vallejos, Catalina A Andrade, Guillermo Hoppe-Elsholz, Carolina Iturriaga, Marcela Urzua, María S Navarrete, Álvaro Rojas, Rodrigo Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Mónica L Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Daniela Weiskopf, Alba Grifoni, Alessandro Sette, Gang Zeng, Weining Meng, CoronaVacCL03 Study Group, José V González-Aramundiz, Marina Johnson, David Goldblatt, Pablo A González, Katia Abarca, Susan M Bueno, Alexis M Kalergis
Publikováno v:
eLife, Vol 11 (2022)
Background: The development of vaccines to control the coronavirus disease 2019 (COVID-19) pandemic progression is a worldwide priority. CoronaVac is an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine approved for eme
Externí odkaz:
https://doaj.org/article/ac762f639ff7488791e3508152fce059